TAU discovery may help children suffering from Dravet syndrome
Researchers at Tel Aviv University (TAU) and other institutions have developed an innovative gene therapy that may help children suffering from Dravet syndrome (DS). The severe developmental epilepsy results from a mutation not inherited from the parents but occurring randomly in the fetus in a gene called SCN1A. DS manifests as severe epilepsy that is… Read More